Soros Fund Management’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,000
Closed -$329K – 347
2026
Q2
$329K Buy
+10,000
New +$289K ﹤0.01% 259

Other funds holding AVLN

Soros Fund Management's AVLN Position: Q3 2026 in Review

Soros Fund Management sold out of Avalyn Pharma (AVLN) in Q3 2026, closing a stake of 10,000 shares — an estimated $329K sold.

Soros Fund Management first reported a position in AVLN in Q2 2026 and held it in 1 quarter. The position peaked at $329K in Q2 2026. 113 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Soros Fund Management reported no remaining Avalyn Pharma position as of Q3 2026 after selling out during the quarter.
  • Soros Fund Management sold 10,000 Avalyn Pharma shares in Q3 2026, an estimated $329K.
  • Soros Fund Management first reported a position in Avalyn Pharma in Q2 2026 and held it in 1 quarter.
  • Soros Fund Management's Avalyn Pharma position peaked at $329K in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Soros Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.